Walleye Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-164,900
| Closed | -$28.4M | – | 6235 |
|
|
2021
Q3 | $28.4M | Buy |
164,900
+161,200
| +4,357% | +$21.1M | 0.1% | 189 |
|
|
2021
Q2 | $464K | Buy |
3,700
+2,800
| +311% | +$353K | ﹤0.01% | 3004 |
|
|
2021
Q1 | $122K | Sell |
900
-400
| -31% | -$51.7K | ﹤0.01% | 3998 |
|
|
2020
Q4 | $166K | Sell |
1,300
-11,200
| -90% | -$1.31M | ﹤0.01% | 3651 |
|
|
2020
Q3 | $1.41M | Buy |
12,500
+8,500
| +213% | +$846K | 0.01% | 1392 |
|
|
2020
Q2 | $381K | Buy |
4,000
+3,300
| +471% | +$318K | ﹤0.01% | 2507 |
|
|
2020
Q1 | $63K | Buy |
700
+300
| +75% | +$23.3K | ﹤0.01% | 3345 |
|
|
2019
Q4 | $21K | Buy |
+400
| New | +$18.2K | ﹤0.01% | 3986 |
|
|
2019
Q3 | – | Sell |
-2,200
| Closed | -$90K | – | 4587 |
|
|
2019
Q2 | $90K | Sell |
2,200
-7,400
| -77% | -$306K | ﹤0.01% | 3350 |
|
|
2019
Q1 | $447K | Buy |
+9,600
| New | +$421K | ﹤0.01% | 2371 |
|
|
2018
Q4 | – | Sell |
-12,000
| Closed | -$687K | – | 5602 |
|
|
2018
Q3 | $687K | Buy |
+12,000
| New | +$590K | ﹤0.01% | 2524 |
|
|
2018
Q2 | – | Sell |
-3,800
| Closed | -$149K | – | 5060 |
|
|
2018
Q1 | $149K | Sell |
3,800
-19,900
| -84% | -$846K | ﹤0.01% | 3705 |
|
|
2017
Q4 | $1.01K | Buy |
+23,700
| New | +$889K | ﹤0.01% | 1939 |
|
Walleye Trading's XLRN Position: Q4 2021 in Review
Walleye Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 27,259 shares — an estimated $4.69M sold.
Walleye Trading first reported a position in XLRN in Q4 2018 and held it in 7 quarters. The position peaked at $4.69M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Walleye Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Walleye Trading sold 27,259 Acceleron Pharma shares in Q4 2021, an estimated $4.69M.
- Walleye Trading first reported a position in Acceleron Pharma in Q4 2018 and held it in 7 quarters.
- Walleye Trading's Acceleron Pharma position peaked at $4.69M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.